Skip to main content
Clinical Trials/TCTR20200505006
TCTR20200505006Not yet recruitingPhase 2

Dose related effect of Extracorporeal Shock wave therapy for chronic plantar fasciitis between fix and titrate dose: Randomized controlled trial

o0 sites72 target enrollmentStarted: May 5, 2020Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
o
Enrollment
72

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 60 Years (—)
Sex
All

Inclusion Criteria

  • 1.age 18 - 60 years old
  • 2.Diagnosed by orthopedist : pain at medial foot when start walking and tender at medial calcalneal tuberosity and symptoms more than 3 months

Exclusion Criteria

  • 1.brain and recognitive impairment
  • 2.Body Mass Index morethan 30 kg/m2
  • 3.Visual Analog Scale (VAS) lessthan 2
  • 4.recieve steriod injection or shockwave within 3 month
  • 5.history of calcaneal fracture or foot and ankle surgery
  • 6.systemic disorders: infection, Gout ,Rheumatoids,bone tumor
  • 7.pregnancy
  • 8.on pacemaker
  • 9. Bleeding disorder: Hemophilia

Investigators

Sponsor
o

Similar Trials

Dose related effect of Extracorporeal... | Clinical Trial